INEOS SILICAS NETHERLANDS B.V. – Trademark Portfolio

Entity Type: 03

INEOS SILICAS NETHERLANDS B.V. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include GASIL, ZEOCROS, and LUCILITE. The owner is based in EIJSDEN.

INGENIEUR ROCOURSTRAAT 28

EIJSDEN 6245 AD , NL

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZEOCROS
ZEOCROS
Registered 2000
CRYSTAL
CRYSTAL
Cancelled 1995
DOUCIL
DOUCIL
Cancelled 1993
LUCILITE
LUCILITE
Registered 1988
GASIL
GASIL
Registered 1973

Trademark Classifications

INEOS SILICAS NETHERLANDS B.V.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (5 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does INEOS SILICAS NETHERLANDS B.V. have?

INEOS SILICAS NETHERLANDS B.V. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.

What trademark classes does INEOS SILICAS NETHERLANDS B.V. file in?

INEOS SILICAS NETHERLANDS B.V. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are INEOS SILICAS NETHERLANDS B.V.'s most well-known trademarks?

INEOS SILICAS NETHERLANDS B.V.'s registered trademark portfolio includes well-known marks such as GASIL, ZEOCROS, and LUCILITE. These are among 3 currently registered trademarks in the portfolio.

What is INEOS SILICAS NETHERLANDS B.V.'s trademark registration success rate?

INEOS SILICAS NETHERLANDS B.V. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.